Enochian Biosciences is a Los Angeles based biopharmaceutical company dedicated to identifying, developing, manufacturing, and commercializing gene-modified cell therapy. Their gene-modified cell therapy platform is applied to multiple indications including HIV and various solid tumor cancers. In 2019, Seraph Research Institute entered into a framework agreement with Enochian Biosciences to function as Enochian’s incubator to develop new potential therapeutic agents that support Enochian’s mission.